EGFR and non-small cell lung carcinoma: In addition, miR-21 was found to be involved in the acquired resistance of EGFR-TKI in NSCLC (in vivo and in vitro), through the downregulation of PTEN, PDCD4 and by the activation PI3K/Akt pathway [204].